Federal Court Stays Class Action Against CBD Firm Green Roads To Await FDA Rulemaking

Plaintiffs against Florida-based Green Roads used certificates of analysis the company makes freely available to consumers to determine that batches of two of the company’s products contained “significantly” less cannabidiol versus labeled amounts. A Florida federal court rejected the firm’s motion to dismiss, but it is interested in seeing how FDA rulemaking develops.

CBD Molecule

Companies marketing ingestible cannabidiol-containing products should add Snyder et al v. Green Roads of Florida, LLC to their list of federal court cases to watch.

Though they could have a lengthy wait to see how the litigation unfolds.

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America